Skip to content
Global Access Atlas

Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

Philippines

FDA registration is followed by separate HTA Council recommendations, DOH formulary/programme choices, PhilHealth benefit packages, price regulation, procurement and provider delivery.

FDA Center for Drug Regulation and Research / local applicant
company / DOH / PhilHealth / HMO/provider
DOH or PhilHealth / DOST HTA Division / HTAC
assessor / HTAC / stakeholders
HTAC / Secretary of Health or PhilHealth decision-maker
9 decision nodes15 cited sources

For education only — not regulatory, pricing or legal advice.

About the content and how to use it